David A. Siegel Solid Biosciences Inc. Transaction History

Two Sigma Advisers, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.51 - $7.56 $20,145 - $298,620	-39,500 Reduced 17.43%	187,100 $87,000
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $62,952 - $181,536	-146,400 Reduced 39.25%	226,600 $139,000
Q1 2022 May 16, 2022	SELL	$0.74 - $1.79 $149,258 - $361,043	-201,700 Reduced 35.1%	373,000 $448,000
Q4 2021 Feb 14, 2022	BUY	$1.69 - $2.46 $45,461 - $66,174	26,900 Added 4.91%	574,700 $1.01 Million
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $2.23 Million - $3.53 Million	-935,800 Reduced 63.08%	547,800 $1.31 Million
Q2 2021 Aug 16, 2021	BUY	$3.49 - $5.51 $2.79 Million - $4.41 Million	799,600 Added 116.9%	1,483,600 $5.43 Million
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $1.97 Million - $3.93 Million	366,400 Added 115.37%	684,000 $3.78 Million
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $483,560 - $1.22 Million	157,000 Added 97.76%	317,600 $2.41 Million
Q3 2020 Nov 16, 2020	BUY	$2.02 - $3.08 $28,684 - $43,736	14,200 Added 9.7%	160,600 $326,000
Q2 2020 Aug 14, 2020	BUY	$2.1 - $3.42 $126,420 - $205,884	60,200 Added 69.84%	146,400 $429,000
Q1 2020 May 15, 2020	BUY	$2.31 - $4.43 $169,554 - $325,162	73,400 Added 573.44%	86,200 $206,000
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $36,096 - $165,120	12,800 New	12,800 $57,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $30.4M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.